Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GALT PHARMS

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 27
  • 0 comments

FDA approve QUAZEPAM

Comment Full text

HIKMA

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 22
  • 0 comments

FDA approve LORAZEPAM

Comment Full text

PFIZER

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 28
  • 0 comments

FDA approve TRIAZOLAM

Comment Full text

BAUSCH

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 25
  • 0 comments

FDA approve LORAZEPAM

Comment Full text

CHEPLAPHARM

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 24
  • 0 comments

FDA approve CLONAZEPAM

Comment Full text

KEY THERAP

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 22
  • 0 comments

FDA approve CLORAZEPATE DIPOTASSIUM

Comment Full text

HERITAGE PHARMS INC

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 26
  • 0 comments

FDA approve AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE

Comment Full text

BAUSCH

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 28
  • 0 comments

FDA approve CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE

Comment Full text

UNICHEM

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 27
  • 0 comments

FDA approve ALLOPURINOL

Comment Full text

MSN LABS PVT LTD

  • FDA Approval
  • Jan. 16, 2023, 12:41 UTC
  • 27
  • 0 comments

FDA approve TASIMELTEON

Comment Full text
  • Previous
  • 902
  • 903
  • 904
  • 905
  • 906
  • Next

Search

News categories

  • Technical Exchange News(12261)
  • Event(6229)
  • SEC News(265705)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(155228)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin